Crossmark

Multi-phase hybrid metabolomics framework identifies clinically applicable plasma signatures for early detection of gastric cancer

Crossref DOI link: https://doi.org/10.1038/s41467-026-72983-8

Published Online: 2026-05-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bai, Liyi https://orcid.org/0000-0002-1627-7376
Hu, Fayong

Zhang, Weiqin https://orcid.org/0000-0003-2570-586X
Peng, Huanqin

Peng, Haowen

Li, Huan

Zhu, Xu

Xie, Yibin https://orcid.org/0009-0003-1306-0264
Zhang, Shutian https://orcid.org/0000-0003-2356-4397
Min, Li https://orcid.org/0000-0001-9595-5536
License Information

Text and Data Mining valid from 2026-05-13

Accepted Manuscript valid from 2026-05-13
More Information

Article History

Received: 22 September 2025

Accepted: 24 April 2026

First Online: 13 May 2026

Competing interests

: The authors declare no competing interests.